


Strand Therapeutics Revenue
Biotechnology Research • Boston, Massachusetts, United States • 101-200 Employees
Strand Therapeutics revenue & valuation
| Annual revenue | $2,300,000 |
| Revenue per employee | $22,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $7,400,000 |
| Total funding | $198,000,000 |
Key Contacts at Strand Therapeutics
Tyler Andolina-Cabral
Director Of People Sciences
Tasuku Kitada
Co-Founder, Board Director, President, And Head Of R&D
Caitlin Minnette
Sr. Director Quality Operations
Jaspreet Khurana
Senior Director, Mrna Programming
Mauricio Barraza
Director Of Manufacturing
Ryan Sowell
Director, Translational Biology
Alexander Lemaire
Associate Director Of Process Development
Samriti Bhambi
Senior Director, Fp&A
Kevin Shi
Director, Computational Biology
Daniel Dzurko
Associate Director, Analytical Development
Company overview
| Headquarters | 21-27 Burlington Ave, Boston, Massachusetts 02215, US |
| Phone number | +13093609875 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Immunotherapy, Synthetic Biology, Rna Therapeutics |
| Founded | 2017 |
| Employees | 101-200 |
| Socials |
Strand Therapeutics Email Formats
Strand Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@strandtx.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@strandtx.com | 60% |
{first name}.{last name} | john.doe@strandtx.com | 37.1% |
{first initial}.{last name}{last name} | j.doedoe@strandtx.com | 1.4% |
{second initial}.{last name} | o.doe@strandtx.com | 1.4% |
About Strand Therapeutics
Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies. Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Strand Therapeutics has 27 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Strand Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Strand Therapeutics Tech Stack
Discover the technologies and tools that power Strand Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Video players
Performance
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
Databases
JavaScript libraries
Webmail
Programming languages
Security
Blogs
Frequently asked questions
4.8
40,000 users



